Clinical Trials Sponsored by TEVA Pharmachemie

Total 793 results

Teva Pharmaceuticals USA

Completed

Azithromycin 600 Mg Tablets, Fed

Healthy

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Meloxicam 15 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Lamotrigine 25 mg Chewable Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Granisetron 1 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Glimepiride 4 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Metformin ER 750 mg Tablets, Fed

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Famciclovir 500 mg Tablets Under Fasting Conditions

Healthy

United States, Canada
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir Capsules 300 mg, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir Capsules 300 mg, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefprozil 500 mg Tablets Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Zaleplon 10 mg Capsules Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Trandolapril 4 mg Tablet Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Amlodipine 10 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Healthy

Germany
Teva Pharma GmbH

Completed

Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Patient Satisfaction

Germany
Teva Pharmaceuticals Europe

Completed

Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease (SPRINT)

Chronic Obstructive Pulmonary Disease | Asthma

Croatia, Denmark, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom
Teva Women's Health

Completed

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

Oral Contraceptive | Hemostasis

United States, Italy
Teva Neuroscience, Inc.

Completed

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Parkinson's Disease
Teva Neuroscience, Inc.

Completed

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

Multiple Sclerosis
Teva Pharmaceuticals USA
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal

United States, Bulgaria, Czechia, Georgia, Germany, Hungary, Poland, Russian Federation, Slovakia, Ukraine
Teva Pharma GmbH

Completed

A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.

Pregnancy Rate | Oocytes

Germany
Teva Neuroscience, Inc.

Completed

A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

Multiple Sclerosis

United States
Teva Neuroscience, Inc.

Completed

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

Multiple Sclerosis
McMaster University
Teva Canada

Completed

Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma

Asthma; Eosinophilic

Canada
Teva Neuroscience, Inc.

Completed

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients (ENCORE)

Multiple Sclerosis
Teva Women's Health

Completed

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Pregnancy Prevention

United States

3

Subscribe